Cholestatic hepatocellular injury: What do we know and how should we proceed

Journal of Hepatology

Volumn 42, Issue 3, 2005, Pages 297-300

  Guicciardi, Maria Eugenia ^a   Gores, Gregory J ^a  

^a MAYO CLINIC COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEATH RECEPTOR 5; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; MULTIDRUG RESISTANCE PROTEIN 4; PROTEIN BCL 2;

BILE DUCT LIGATION; CHOLECYSTECTOMY; CHOLESTASIS; COMMON BILE DUCT; COMMON BILE DUCT OBSTRUCTION; EDITORIAL; GENE MUTATION; HUMAN; INTRACELLULAR MEMBRANE; LIVER CELL DAMAGE; LIVER FIBROSIS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 13844275260     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2004.12.014     Document Type: Editorial

References (44)

1. Y. Liu, J. Binz, M.J. Numerick, S. Dennis, G. Luo, and B. Desai Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis J Clin Invest 112 2003 1678 1687
2. R. Pellicciari, S. Fiorucci, E. Camaioni, C. Clerici, G. Costantino, and P.R. Maloney 6alpha-ethyl-chenodeoxycholic acid (6-ECDCA), a potent and selective FXR agonist endowed with anticholestatic activity J Med Chem 45 2002 3569 3572
3. M. Wagner, P. Fickert, G. Zollner, A. Fuchsbichler, D. Silbert, and O. Tsybrovskyy Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice Gastroenterology 125 2003 825 838
4. J.M. De Vree, R. Ottenhoff, P.J. Bosma, A.J. Smith, J. Aten, and R.P. Oude Elferink Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis Gastroenterology 119 2000 1720 1730
5. P. Fickert, A. Fuchsbichler, M. Wagner, G. Zollner, A. Kaser, and H. Tilg Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127 2004 261 274
6. K. Miyai, A.L. Richardson, W. Mayr, and N.B. Javitt Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5- cholenoic, cholic, and dehydrocholic acids Lab Invest 36 1977 249 258
7. D.L. Schmucker, M. Ohta, S. Kanai, Y. Sato, and K. Kitani Hepatic injury induced by bile salts: correlation between biochemical and morphological events Hepatology 12 1990 1216 1221
8. S.S. Strautnieks, L.N. Bull, A.S. Knisely, S.A. Kocoshis, N. Dahl, and H. Arnell A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis Nat Genet 20 1998 233 238
9. R. Thompson, and S. Strautnieks BSEP: function and role in progressive familial intrahepatic cholestasis Semin Liver Dis 21 2001 545 550
10. P.J. Meier, and B. Stieger Bile salt transporters Annu Rev Physiol 64 2002 635 661
11. P.L. Jansen, S.S. Strautnieks, E. Jacquemin, M. Hadchouel, E.M. Sokal, and G.J. Hooiveld Hepatocanalicular bile salt export pump deficiency in patients with progressive familial intrahepatic cholestasis Gastroenterology 117 1999 1370 1379
12. C. Gartung, M. Ananthanarayanan, M.A. Rahman, S. Schuele, S. Nundy, and C.J. Soroka Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis Gastroenterology 110 1996 199 209
13. J.D. Ostrow Metabolism of bile salts in cholestasis in humans N. Tavoloni P. Berk Hepatic transport and bile secretion 1993 Raven Press New York, NY 673 712
14. M.G. Donner, and D. Keppler Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver Hepatology 34 2001 351 359
15. C.J. Soroka, J.M. Lee, F. Azzaroli, and J.L. Boyer Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver Hepatology 33 2001 783 791
16. M. Arrese, and M. Trauner Molecular aspects of bile formation and cholestasis Trends Mol Med 9 2003 558 564
17. M. Bertolotti, L. Carulli, M. Concari, P. Martella, P. Loria, and E. Tagliafico Suppression of bile acid synthesis, but not of hepatic cholesterol 7alpha-hydroxylase expression, by obstructive cholestasis in humans Hepatology 34 2001 234 242
18. H. Kurosawa, F.G. Que, L.R. Roberts, P.J. Fesmier, and G.J. Gores Hepatocytes in the bile duct-ligated rat express Bcl-2 Am J Physiol 272 1997 G1587 G1593
19. M.H. Schoemaker, W.M. Gommans, L.C. de la Rosa, M. Homan, P. Klok, and C. Trautwein Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation J Hepatol 39 2003 153 161
20. H. Miyoshi, C. Rust, P.J. Roberts, L.J. Burgart, and G.J. Gores Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas Gastroenterology 117 1999 669 677
21. A. Canbay, A.E. Feldstein, H. Higuchi, N. Werneburg, A. Grambihler, and S.F. Bronk Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression Hepatology 38 2003 1188 1198
22. J.S. Gujral, A. Farhood, M.L. Bajt, and H. Jaeschke Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice Hepatology 38 2003 355 363
23. M.E. Guicciardi, and G.J. Gores Bile acid-mediated hepatocyte apoptosis and cholestatic liver disease Digest Liver Dis 34 2002 387 392
24. W.A. Faubion, M.E. Guicciardi, H. Miyoshi, S.F. Bronk, P.J. Roberts, and P.A. Svingen Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas J Clin Invest 103 1999 137 145
25. T. Sodeman, S.F. Bronk, P.J. Roberts, H. Miyoshi, and G.J. Gores Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas Am J Physiol Gastrointest Liver Physiol 278 2000 G992 G999
26. S. Gupta, R. Natarajan, S.G. Payne, E.J. Studer, S. Spiegel, and P. Dent Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation J Biol Chem 279 2004 5821 5828
27. L. Qiao, E. Studer, K. Leach, R. McKinstry, S. Gupta, and R. Decker Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and Fas receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis Mol Biol Cell 12 2001 2629 2645
28. R. Reinehr, D. Graf, and D. Haussinger Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation Gastroenterology 125 2003 839 853
29. R. Reinehr, and D. Haussinger Inhibition of bile salt-induced apoptosis by cyclic AMP involves serine/threonine phosphorylation of CD95 Gastroenterology 126 2004 249 262
30. H. Higuchi, S.F. Bronk, Y. Takikawa, N. Werneburg, R. Takimoto, and W. El-Deiry The bile acid glycochenodeoxycholate induces TRAIL-receptor 2/DR5 expression and apoptosis J Biol Chem 276 2001 38610 38618
31. R. Botla, J.R. Spivey, H. Aguilar, S.F. Bronk, and G.J. Gores Ursodeoxycholate (UDCA) inhibits the mitochondrial membrane permeability transition induced by glycochenodeoxycholate: a mechanism of UDCA cytoprotection J Pharmacol Exp Ther 272 1995 930 938
32. A.P. Rolo, P.J. Oliveira, A.J. Moreno, and C.M. Palmeira Chenodeoxycholate is a potent inducer of the permeability transition pore in rat liver mitochondria Biosci Rep 21 2001 73 80
33. F.P. Wachs, R.C. Krieg, C.M. Rodrigues, H. Messmann, F. Kullmann, and R. Knuchel-Clarke Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor Int J Colorectal Dis 2004
34. C.M. Rodrigues, G. Fan, X. Ma, B.T. Kren, and C.J. Steer A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation J Clin Invest 101 1998 2790 2799
35. J.S. Gujral, J. Liu, A. Farhood, and H. Jaeschke Reduced oncotic necrosis in Fas receptor-deficient C57BL/6J-lpr mice after bile duct ligation Hepatology 40 2004 998 1007
36. P. Fickert, M. Trauner, A. Fuchsbichler, G. Zollner, M. Wagner, and H-U. Marschall Oncosis represents the main type of cell death in mouse models of cholestasis J Hepatol 42 2005 378 385
37. A. Canbay, H. Higuchi, S.F. Bronk, M. Taniai, T.J. Sebo, and G.J. Gores Fas enhances fibrogenesis in the bile duct ligated mouse: a link between apoptosis and fibrosis Gastroenterology 123 2002 1323 1330
38. H. Higuchi, H. Miyoshi, S.F. Bronk, H. Zhang, N. Dean, and G.J. Gores Bid antisense attenuates bile acid-induced apoptosis and cholestatic liver injury J Pharmacol Exp Ther 299 2001 866 873
39. A. Canbay, A. Feldstein, E. Baskin-Bey, S.F. Bronk, and G.J. Gores The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse J Pharmacol Exp Ther 308 2004 1191 1196
40. L. Yu, A. Alva, H. Su, P. Dutt, E. Freundt, and S. Welsh Regulation of an ATG7-beclin 1 program of autophagic cell death by caspase-8 Science 304 2004 1500 1502
41. T.M. Caserta, A.N. Smith, A.D. Gultice, M.A. Reedy, and T.L. Brown Q-VD-OPh, a broad spectrum caspase inhibitor with potent antiapoptotic properties Apoptosis 8 2003 345 352
42. F. Martinon, K. Burns, and J. Tschopp The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta Mol Cell 10 2002 417 426
43. B. Becattini, S. Sareth, D. Zhai, K.J. Crowell, M. Leone, and J.C. Reed Targeting apoptosis via chemical design: inhibition of Bid-induced cell death by small organic molecules Chem Biol 11 2004 1107 1117
44. K.L. Valentino, M. Gutierrez, R. Sanchez, M.J. Winship, and D.A. Shapiro First clinical trial of a novel caspase inhibitor: anti-apoptotic caspase inhibitor, IDN-6556, improves liver enzymes Int J Clin Pharmacol Ther 41 2003 441 449